Concepedia
Statistics
Publications
7
Citations
174
H-Index
Active since
2014
Affiliations
Novartis (Japan)(Current)
Novartis (Switzerland)
International University of Health and Welfare
Mitsubishi Tanabe Pharma Corporation
Kyushu University
Isao Tsumiyama is an author at Novartis (Japan) specializing in clinical pharmacology, pharmacotherapy, and multiple sclerosis.
Publications per year
2014–2022
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension
Jun‐ichi Kira, Yasuto Itoyama, Seiji Kikuchi et al. · BMC Neurology · 2014 · 56 citations · Full text
Pharmacy, Neurology, Pharmacotherapy +14
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study
Jun‐ichi Kira, Jin Nakahara, Takayoshi Kurosawa et al. · Multiple Sclerosis Journal · 2021 · 30 citations
Pharmacy, Neurology, Pharmacotherapy +15
Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study
Takahiko Saida, Yasuto Itoyama, Seiji Kikuchi et al. · BMC Neurology · 2017 · 24 citations · Full text
Medicine, Neurology, Pharmacotherapy +14
Dose‐dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity
Koutaro Yokote, Misako Sano, Isao Tsumiyama et al. · Diabetes Obesity and Metabolism · 2020 · 24 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
Takahisa Hirose, Manabu Suzuki, Isao Tsumiyama · Diabetes Therapy · 2015 · 18 citations · Full text
Medicine, Endocrinology, Pharmacology +17
1–5 of 7